15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Geron Corporation, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $4.00 to $4.00, so the covering firms are broadly aligned. The average target of $4.00 sits 175% above the current $1.46. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.01 next quarter toward $0.06 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Geron Corporation.
As of Jul, 1 of 1 firms rate GERN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GERN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.01
Range $-0.01 – $0.00 · 2 analysts · -83% YoY
Next period, 2 analysts expect Geron Corporation to earn $-0.01 a share (range $-0.01 – $0.00), versus $-0.03 a year earlier. Full-year consensus is $-0.02, growing to $0.06 the year after.
REVENUE · NEXT QUARTER
$60.0M
Range $57.5M – $62.4M · 2 analysts · +27% YoY
Revenue is expected to reach $60.0M (range $57.5M – $62.4M), +27.0% year-over-year. Full-year consensus is $234.2M, rising to $342.3M next year.
Top analysts covering Geron Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GERN.
#1
Greg Harrison
Scotiabank · Rank #177
Hold
$1.50+3.1% to target
Overall win rate
38%
+ Follow
#2
Gil Blum
Needham · Rank #298
Buy
$4.00+174.9% to target
Overall win rate
24%
+ Follow
#3
Emily Bodnar
HC Wainwright & Co. · Rank #338
Hold
No targeton GERN
Overall win rate
22%
+ Follow
#4
Peter Lawson
Barclays
Buy
No targeton GERN
Coverage
—
+ Follow
#5
Corinne Johnson
Goldman Sachs
Sell
$1.00-31.3% to target
Coverage
—
+ Follow
GERN stock forecast FAQ
What is GERN's average 12-month price target?+
The 1 analysts with a live target average $4.00 for Geron Corporation over the next 12 months, ranging from a $4.00 high to a $4.00 low.
Is GERN stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover GERN?+
1 analysts have an active rating on Geron Corporation, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering GERN?+
Among analysts who currently cover GERN, Greg Harrison of Scotiabank has the strongest overall Quantellect track record (Rank #177). Their current call is Hold with a $1.50 target.
What is Geron Corporation's projected EPS for next quarter?+
The consensus estimate is $-0.01 per share (range $-0.01 – $0.00) across 2 analysts. Full-year EPS is projected at $-0.02, rising to $0.06 the following year.
How much revenue is Geron Corporation expected to report next quarter?+
Consensus revenue is $60.0M (range $57.5M – $62.4M). Full-year revenue is projected at $234.2M, growing to $342.3M next year.
Have analysts been upgrading or downgrading GERN lately?+
As of Jul, 1 of 1 firms rate GERN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GERN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
